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Objective: Memory deficits have been shown in patients
affected by schizophrenia (SZ) and bipolar (BP)/mood dis-
order.Werecentlyreportedthatyounghigh-riskoffspringof
an affected parent were impaired in both verbal episodic
memory (VEM) and visual episodic memory (VisEM). Un-
derstanding better the trajectory of memory impairments
from childhood to adult clinical status in risk populations
is crucial for early detection and prevention. In multigener-
ationalfamiliesdenselyaffectedbySZorBP,ouraimwasto
comparethememoryimpairmentsobservedinyoungnonaf-
fected offspring with memory functioning in nonaffected
adult relatives and patients. Methods: For 20 years, we
followed up numerous kindreds in the Eastern Que ´bec pop-
ulation. AfterhavingcharacterizedtheDiagnosticandSta-
tistical Manual of Mental Disorders phenotypes, we
assessed cognition (N 5 381) in 3 subsamples in these kin-
dredsandincontrols:60youngoffspringofaparentaffected
by SZ or BP, and in the adult generations, 92 nonaffected
adult relatives and 40 patients affected by SZ or BP.
VEM was assessed with the California Verbal Learning
Test and VisEM with the Rey figures. Results: The VEM
deficitsobservedintheoffspringwerealsofoundinadultrel-
ativesandpatients.Incontrast,theVisEMimpairmentsob-
served in the young offspring were present only in patients,
not in the adult relatives. Conclusion: Implications for pre-
vention and genetic mechanisms can be drawn from the ob-
servation that VEM and VisEM would show distinct
generational trajectories and that the trajectory associated
with VisEM may offer a better potential than VEM to pre-
dict future risk of developing the disease.
Key words: schizophrenia/mood disorders-bipolar/
child psychiatry/cognitive neuroscience
Introduction
Meta-analyses have shown that episodic memory is
among the most impaired neurocognitive domains in
schizophrenia (SZ) and in bipolar (BP) affective
patients.
1–4 Effect sizes (ESs) are large in SZ patients
(>1.0) and moderate to large in BP patients (between
0.6 and 1.0) in the verbal episodic memory (VEM) and
visual episodic memory (VisEM) domains,
5 although
VisEM has been less extensively investigated than
VEM.
6,7 Interestingly, in the study of Skelley et al,
5 adult
SZ patients displayed both VEM and VisEM deficits,
whereas their adult nonaffected relatives had only
VEM impairments. The mechanistic meaning of this dif-
ferential pattern is unclear. Several studies suggest that
memory deficits may be shared by SZ and BP, although
BP patients are generally found less impaired than SZ.
8,9
We recently reported in this Journal that the young
high-risk (HR) offspring of SZ or BP parents shared im-
portant deficits in both VEM and VisEM,
10 in fact the
largest differences with normal controls were for these
2 cognitive domains (ESs of ;0.8–0.9). This suggested
that the memory impairments seen in patients would al-
ready exist in childhood/adolescence. However, little
knowledge exists about the long-term predictive effect
of memory impairments present early in life in popula-
tions at risk for SZ or BP.
A better understanding of the trajectory of such epi-
sodicmemorydysfunctions from childhood toadulthood
in risk populations is crucial for early detection, preven-
tion, and comprehension of the genetic architecture of
major psychoses. Longitudinal cohort studies starting
in childhood take a long time to yield results, and the
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1218alternative strategy of accelerated longitudinal designs is
also difficult to perform.
11 We conceived an approach
combining cross-sectional assessments in 3 complemen-
tary subsamples of different generations drawn from
our Eastern Que ´bec large multigenerational kindreds
densely affected by SZ or BP that were characterized
andfollowedupover20years.
12,13The3subsamplescon-
sisted of (1) young nonaffected offspring of a parent af-
fected by SZ or BP, (2) nonaffected adult relatives from
the older generations, and (3) the patients, ie, the adult
family members affected by SZ or BP.
Using a cross-sectional generational stratification in
our kindreds, the objective of the present study was to
compare the VEM and VisEM impairments observed in
the young offspring with the impairments in nonaffected
adult relatives and patients. To our knowledge, this is
the first study to investigate simultaneously, and with
the same methodology, the neurocognitive impairments
in episodic memory in young offspring and also in the
affected and nonaffected adults from the same kindreds.
Methods
Sample
Ascertainment of Kindreds. We targeted all the multi-
generational families densely affected by SZ or BP in
the Eastern Que ´bec (Canada) catchment area. Families
‘‘inclusion criteria’’ were (1) having at least one first-de-
gree relative affected with the same disorder (SZ/BP) as
the proband and (2) having at least 4 affected individuals
sharing the same disorder. We gathered 48 SZ or BP kin-
dreds over 20 years with an average of 26 members per
kindred including an average of 6 affected by SZ or
BP. The mean age of onset was 25.4 (SD 8.5) years for
SZ and 28.8 (SD 10.3) years for BP. More details about
the kindreds ascertainment have already been provided
elsewhere.
13–17
YoungOffspringSubsample. Weenlargedthepreviously
reported HR offspring sample drawn from the youngest
generations of the kindreds.
10 As previously described,
10
the inclusion criteria were (1) having a parent with a def-
inite Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition (DSM-IV) SZ or BP disorder and (2)
having had a neuropsychological evaluation before being
23-year old. The offspring ‘‘exclusion criteria’’ were the
presence of a diagnosis of DSM-IV psychotic disorder,
BP or major depression, and brain and metabolic disor-
ders known to cause neuropsychological impairments.
Comparedwith ourformerreport,
10the offspringsample
was increased from 45 to 60 subjects (mean age = 17.4
years, SD 4.1, 51.7% males). Considering the exclusion
criteria in the present sample, 37% of these 60 HR off-
springs had an axis I nonpsychotic diagnoses distributed
as follow: anxiety-like disorder 17%, substance abuse 5%,
attention-deficit hyperactivity disorder 8%, and learning
andlanguagedisorder7%.Twenty-fiveofthemhadapar-
ent affected by SZ, while 35 had a parent affected by BP.
The offspring sample was composed of 40 sibships of
which 23 comprised a single subject, 14 comprised 2,
and 3 comprised 3.
Nonaffected Adult Relatives Subsample. The inclusion
criteria were (1) having a first-degree relative with a def-
inite DSM-IV SZ or BP disorder and (2) having had
a neuropsychological evaluation before being 55-year
old. The exclusion criteria were the same as in offspring
above. Ninety-two adult relatives were evaluated (mean
age = 40.2 years, SD 10.5), 26 of them had a first-degree
relative affected by SZ, 46 had a first-degree relative af-
fected by BP, while the 20 remaining adult relatives had
one first-degree relative affected by SZ and another by
BP. Sixty-nine of the 92 adult relatives were the offspring
of an affected parent, whereas 23 participants were either
sibs or parents of a patient. Thirty percent of these adult
relatives had an axis I nonpsychotic diagnoses: anxiety-
like disorder 20%, substance abuse 8%, attention-deficit
hyperactivity disorder 1%, and language disorder 1%.
This nonaffected relatives sample spanned 48 sibships
of which 36 comprised a single subject, 12 comprised
2, 8 comprised 3, and 2 comprised 4.
PatientsSubsample. The adult members affected by SZ
or BP came from the same large densely affected multi-
generational kindreds.
13,14,18 The inclusion criteria were
(1) a definite DSM-IV SZ or a BP diagnosis, (2) having
undergone a neuropsychological evaluation before age
55, and (3) being in a clinical status allowing a reliable
cognitive assessment. The exclusion criteria were a brain
disorder, trauma, and metabolic disorder known to cause
neuropsychological impairments. The present sample
consisted of 40 patients (20 SZ and 20 BP, mean age =
43.7 years, SD 10.0, 40% men). The patient sample
spanned 35 sibships of which 30 comprised a single pa-
tient and 5 comprised 2. Twenty-seven of the 40 patients
had at least one first-degree relative among the 60 young
offspring or the 92 nonaffected relatives, 12 of them
(30%) had second- or third-degree relatives, and only
1 (2%) was not related to any of the subjects from the
other 2 subsamples.
Healthy Control Subsample. Two different unrelated
control groups (n = 189) were used: an adult healthy con-
trol group (N = 113, mean age = 34.6 years, SD 9.9; 38%
men)forboththenonaffectedrelativesandadultpatients
and a young healthy control group (N = 76, mean age =
16.9 years, SD 4.0; 50% males) for the offspring. The
2 study groups were balanced for age and gender with
each of the 2 experimental subsamples. Participants
were recruited in response to advertisements and were
from the same population as the experimental subjects.
Selective Generational Patterns of Verbal and Visual Memory
1219Theexclusioncriteriawerethesameasthoseforoffspring
andnonaffectedrelativeswiththeadditionofanylifetime
axisI DSMdiagnosis orapositive familyhistoryofSZ or
BP spectrum disorders.
The study was personally explained, and a signed con-
sent was obtained for all subjects, as reviewed by our
University Ethics Committee.
Measurements
Psychiatric Ascertainment (in Offspring, Nonaffected
Relatives, and Patients). In offspring, the method con-
sisted in a direct interview with the parents and the chil-
dren (K-SADS
19 for subjects under 18 or the Structured
Clinical Interview for DSM-IV
20 for those over 18). A
lifetime best estimate DSM-IV diagnosis used all avail-
able information concerning the offspring,
21 just like
for the parents and relatives.
15,17 A detailed description
ofbestestimatediagnosisanddistributionofdiagnosesin
these offspring has already been reported.
21
The adult relatives and the patients had the same lifetime
bestestimateprocedure,basedoninformationfromadirect
structured interview with the subjects (Structured Clinical
Interview for Diagnostic and Statistical Manual of Mental
Disorder-III-R) and with their relatives as well as on all
available medical records across lifetime. Based on this
information, a consensus diagnosis was derived by a panel
of 4 research psychiatrists who were blind to diagnoses in
relatives.
15–17
Neuropsychological Assessments. All the cognitive do-
mainsassessedbymeansofthefullneuropsychologicalbat-
teryareprovidedinthetable1andSupplementarytableS1
ofthesupplement.Inthisstudy,wefocusedonthefreerecall
measuresofVEMandVisEMtestsbecausetheyshowedthe
largest ESs in the comparison of offspring with controls.
10
VEMwasassessedwiththeCaliforniaVerbalLearningTest
(CVLT)
22‘‘totalanddelayedrecalls’’inwhichsubjectshad
tolearnaseriesofwordspresentedorallyover5trials,andto
immediatelyrecallthemaftereachpresentation(totalrecall
of 5 trials), or with a 20-min delay (delayed recall). VisEM
wasassessedwiththeReyComplexFigureTest(RCF)
23im-
mediate and delayed recalls. Subjects had to copy a figure
and then recall it after 3 min (immediate recall) and
30 min (delayed recall). The tests were administered in
thesameorderinallsubjects,withchild,adolescent,oradult
versions,dependingontheageofthesubject.Subjectswere
individually assessed in a quiet room for a period of 3–4 h
(forthe full battery; see supplement)bycertifiedpsycholo-
gists or PhD students who were blind to diagnoses and su-
pervisedbyaseniorneuropsychologist(N.R.).Pauseswere
offered when needed.
Statistical Analysis
First, the average raw scores on the cognitive tests were
compared for each of the experimental groups (young
offspring, nonaffected adult relatives, and patients) to
the appropriate control group by means of analyses of
covariance (ANCOVAs). Age and gender were selected
as covariables in all our statistical analyses. To account
for the nonindependence of observations within the same
sibship, a multilevel regression analysis was applied with
the MIXED procedure of SAS (version 9.1.3; SAS Insti-
tute Inc., Cary, NC). Sibships nested in the group were
used as the second level and modeled according to a
random effect. Degrees of freedom were obtained by
the method of Kenward–Roger
24, ie, available with the
option DDFM = KR in the MODEL statement of the
MIXED procedure. ESs were calculated using the differ-
ence of adjusted means (LSMeans) between the experi-
mental and control groups standardized by a pooled
SD. The pooled SD was obtained by dividing the SE
of the difference of LSMeans by the square root
of 1
n1 þ 1
n2
25 Confidence intervals (CIs) for the ESs were
obtained using the noncentrality interval estimation
approach based on a ‘‘t’’ distribution.
26 The lower and
upper bounds of the 95% CI were calculated by multiply-
ing the 2.5% and 97.5% percentiles, respectively, of the
noncentral ‘‘t’’ distribution by the square root of n1þn2
n13n2.
Multiple Testing. To account for the multiple tests
involved, we calculated corrected P values using the
method of Hochberg
27 which consists of ordering the
raw P values and adjusting the sequence of value accord-
ing to a step-up fashion. The significance level was fixed
at .05.
Results
Comparisons of Young Offspring, Adult Relatives, and
Patients to Their Respective Controls
Forthe‘‘youngoffspring,’’thecomparisonsinthepresent
enlarged sample yielded results similar to those recently
reported,
10 and episodic memory showed the largest ES
across the domains assessed by our battery (see figure 1
and table S1). The ESs were large not only for VEM (re-
spectively, ES of  0.84, PANCOVA = 0.0001 and  0.95,
PANCOVA < 0.0001 on the CVLT total recall and delayed
recall)butalsoforVisEMonthe‘‘Reyfiguresimmediate’’
and delayed recall (respectively, ES =  0.86, PANCOVA =
0.0001and 0.92,PANCOVA<0.0001).Toassessthepos-
sibility that the memory differences might be mainly due
toasubgroupbeinginaprodromalstate,westratifiedthe
offspring sample into those under 17 years (N = 25)
vs those over 17 (N = 35). The ES were large in these
2 age strata, respectively, VEM CVLT total recall:E S=
 0.69, PANCOVA < 0.05 and ES =  0.96, PANCOVA <
0.05,andforVisEM Rey delayed recall:ES= 1.32,PANCOVA
< 0.05, and ES =  0.71, PANCOVA < 0.05. The ‘‘nonaf-
fected adult relatives’’ (figure 1 and table 1) showed
also a significant difference from controls for VEM on
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M. Maziade et al.Table 1. Comparisons in Patients, Nonaffected Relatives, and Controls on the Full Neuropsychological Battery
Multilevel Model
a Adjusted for Age and Gender
Post Hoc Analyses
Adjusted Mean (SE) Patients vs Controls NAARs vs Controls
Cognitive Functioning Patients (N = 40)
Nonaffected
Relatives
(N = 92)
Controls
(N = 113)
Global
P Value
b P Value
c ES
d (95% CI
e) P Value
c ES
d (95% CI
e)
Intelligence
Global IQ
f 86.57 (2.01) 98.17 (1.35) 107.4 (1.24) <.0001 <.0001  1.49 ( 1.89,  1.09) <.0001  0.72 ( 1.01,  0.44)
Sustained attention
CPT-hit reaction
time block change
g
 0.003 (0.004)  0.007 (0.003)  0.003 (0.002) .7991  0.0005 ( 0.39, 0.39) 0.16 ( 0.13, 0.44)
CPT-hit standard error block
change
g
 0.02 (0.01)  0.02 (0.01)  0.02 (0.01) .7991  0.04 ( 0.43, 0.36) 0.05 ( 0.23, 0.33)
Selective attention
CPT omissions
g 3.94 (0.67) 2.26 (0.43) 1.03 (0.37) .0090 .0002  0.94 ( 1.35,  0.53) .0869  0.40 ( 0.68,  0.11)
CPT commissions
g 13.69 (1.27) 12.01 (0.80) 10.36 (0.70) .2510  0.56 ( 0.96,  0.16)  0.22 ( 0.50, 0.07)
CPT detectability d’ 0.68 (0.08) 0.79 (0.05) 0.89 (0.05) .2510  0.59 ( 0.99,  0.19)  0.21 ( 0.50, 0.07)
Stroop interference
score
 0.49 (1.93) 0.14 (1.30) 5.27 (1.19) .0411 .5521  0.33 ( 0.69, 0.04) .1079  0.38 ( 0.67,  0.10)
Verbal episodic
memory
CVLT total
recall (VEM)
48.52 (1.45) 54.06 (0.97) 59.15 (0.89) <.0001 <.0001  1.08 ( 1.46,  0.70) .0013  0.59 ( 0.87,  0.31)
CVLT delayed recall 10.19 (0.45) 11.84 (0.30) 12.98 (0.28) <.0001 <.0001  0.99 ( 1.37,  0.61) .0422  0.43 ( 0.71,  0.15)
CVLT recognition 14.33 (0.22) 14.80 (0.15) 15.24 (0.13) .0190 .0032  0.73 ( 1.09,  0.36) .1856  0.33 ( 0.60,  0.05)
Visual episodic
memory
Rey immediate recall 15.31 (0.97) 20.29 (0.65) 21.27 (0.59) <.0001 .0001  0.90 ( 1.28,  0.52) .6778  0.15 ( 0.43, 0.12)
Rey delayed recall
(VisEM)
15.25 (0.94) 20.10 (0.63) 21.48 (0.57) <.0001 <.0001  1.01 ( 1.39,  0.62) .6073  0.22 ( 0.50, 0.06)
Rey recognition 18.85 (0.37) 20.22 (0.25) 20.36 (0.22) .0205 .0282  0.61 ( 0.99,  0.24) .6778  0.06 ( 0.34, 0.22)
Working memory
Total spatial span 14.31 (0.52) 15.77 (0.35) 16.94 (0.32) .0017 .0140  0.65 ( 1.01,  0.28) .1146  0.37 ( 0.64,  0.09)
Total digit span 14.93 (0.68) 16.14 (0.46) 18.46 (0.43) .0002 .0020  0.76 ( 1.13,  0.38) .0058  0.53 ( 0.82,  0.25)
Executive function/
problem solving
WCST total errors
g 38.63 (3.19) 26.42 (2.13) 19.60 (1.91) .0001 .0001  0.94 ( 1.32,  0.55) .0708  0.41 ( 0.70,  0.13)
WCST number of
categories completed
4.13 (0.26) 5.18 (0.17) 5.51 (0.15) .0008 .0004  0.86 ( 1.25,  0.47) .4094  0.28 ( 0.57, 0)
WCST trials
1st category
g
33.55 (3.57) 17.33 (2.38) 17.44 (2.13) .0039 .0412  0.59 ( 0.97,  0.21) .6778  0.12 ( 0.40, 0.16)
WCST failure to
maintain set
g
1.03 (0.20) 0.70 (0.13) 0.79 (0.12) .7991  0.16 ( 0.54, 0.21) 0.06 ( 0.22, 0.34)
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Multilevel Model
a Adjusted for Age and Gender
Post Hoc Analyses
Adjusted Mean (SE) Patients vs Controls NAARs vs Controls
Cognitive Functioning Patients (N = 40)
Nonaffected
Relatives
(N = 92)
Controls
(N = 113)
Global
P Value
b P Value
c ES
d (95% CI
e) P Value
c ES
d (95% CI
e)
WCST learning
to learn
 2.41 (1.04)  1.04 (0.62) 0.26 (0.54) .2510  0.63 ( 1.06,  0.19)  0.29 ( 0.58, 0.01)
Executive function/
initiation
Letter fluency test 9.99 (0.67) 10.73 (0.45) 12.44 (0.41) .0205 .0837  0.51 ( 0.88,  0.15) .0575  0.42 ( 0.69,  0.14)
Category
fluency test
17.47 (0.73) 19.39 (0.49) 21.37 (0.45) .0005 .0056  0.70 ( 1.07,  0.33) .0219  0.47 ( 0.75,  0.19)
Executive function/
planning
Total number of
problems solved
in minute
3.55 (0.42) 5.54 (0.28) 5.22 (0.26) .0043 .0205  0.63 ( 1.00,  0.26) .6778 0.11 ( 0.17, 0.39)
Total time violations
g 1.62 (0.24) 0.93 (0.16) 0.77 (0.14) .0739  0.48 ( 0.86,  0.11)  0.17 ( 0.45, 0.11)
Total rule violations
g 1.05 (0.20) 0.44 (0.14) 0.28 (0.12) .0480 .0675  0.55 ( 0.92,  0.17) .6073  0.22 ( 0.50, 0.06)
Motor coordination
Purdue-both hands 11.03 (0.30) 12.82 (0.20) 13.47 (0.18) <.0001 <.0001  1.29 ( 1.68,  0.89) .1849  0.34 ( 0.61,  0.06)
Note: NAARs, nonaffected adult relatives; CPT-II, Continuous Performance Test-II; CVLT, California Verbal Learning Test; WCST, Wisconsin Card Sorting Test-128
cards.
aTo account for possible correlation among subjects within the same sibship, a multilevel model was carried out using the MIXED procedure of SAS (version 9.1.3; SAS
Institute Inc.). Sibships nested in the group were used as the second level and modeled according to a random effect. Degrees of freedom were obtained by the method of
Kenward–Roger
24 which is available with the option DDFM = KR in the MODEL statement of the MIXED procedure.
bGlobal P values were obtained using the method of Hochberg.
27
cP values were obtained for the cognitive functions showing a global corrected P value < 0.05 using the method of Hochberg.
27
dEffect sizes (ESs) were calculated using the difference of adjusted means (LSMeans) between the experimental and control groups standardized by a pooled SD. The pooled
SD was obtained by dividing the SE of the difference of LSMeans by the square root of 1
n1 þ 1
n2.
25
eConfidence intervals (CIs) for the ESs were obtained using the noncentrality interval estimation approach based on a t distribution.
26 The lower and upper bounds of the
95% CI are calculated by multiplying the 2.5% and 97.5% percentiles, respectively, of the noncentral t distribution by the square root of n1þn2
n13n2.
fGlobal IQ was reported in standardized scores, all the other neuropsychological tests were reported in raw scores corrected for age and gender.
gFor these subtests, an elevated score indicates a subject’s poor performance. Note that the ESs have been inverted for these subtests.
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.the CVLT total recall (ES =  0.59, PANCOVA = 0.0013)
and the CVLT delayed recall (ES =  0.43, PANCOVA =
0.0422). In contrast, VisEM showed no significant differ-
ences between nonaffected relatives and controls on the
Rey immediate recall (ES =  0.15, PANCOVA = 0.68)
and on the Rey delayed recall (ES =  0.22, PANCOVA =
0.61). Finally, ‘‘patients’’ affected by SZ or BP showed
large ESs in both VEM and VisEM (ES ;  1.0) (see
figure 1 and table 1).
Shared Memory Proﬁles in SZ and BP
We tested whether there were differences between the
2 disorders, SZ and BP, in our samples. VEM and VisEM
deficits were observed in both SZ and BP patients, the
latter showing significant differences from controls but
with smaller ESs than SZ: for the CVLT total recall,
ES =  1.45, PANCOVA < 0.05 in SZ patients vs ES =
 0.94, PANCOVA < 0.05 in BP patients (figure 2a),
whereasforthe Rey delayedrecall, ES = 1.17,PANCOVA
< 0.05 in SZ patients vs ES =  0.85, PANCOVA < 0.05
in BP patients (figure 2b). As regards ‘‘the adult rela-
tives,’’ VEM deficits were comparable in relatives of
SZ (ES =  0.60, PANCOVA < 0.05) and relatives of BP
(ES =  0.56, PANCOVA < 0.05). In contrast, as found
in the total sample of adult relatives, VisEM showed
no significant differences from controls in relatives of
SZ and relatives of BP. For ‘‘the high-risk offspring,’’
congruentwith what was previouslyreported,
10 offspring
of SZ and offspring of BP showed very similar deficits
both on VEM (respectively, ES =  0.70, PANCOVA <
0.05 and ES =  0.88, PANCOVA < 0.05) and VisEM (re-
spectively, ES =  0.84, PANCOVA < 0.05 and ES =  0.88,
PANCOVA<0.05).Giventhesefindings,inthesubsequent
analyses, subjects were grouped notwithstanding their
SZ vs BP diagnosis (for patients), and young offspring
and nonaffected relatives were grouped notwithstanding
the diagnoses of their affected relative.
Generational Comparisons
The patterns for VEM and VisEM differed across the
3 subsamples. figure 2 illustrates the ESs observed in
young offspring, in nonaffected adult relatives, and in
patients with their 95% CIs. For VEM, all 3 subsamples
showed significant ESs starting at  0.59 with the addi-
tional feature that patients appeared more impaired
than offspring and the latter worse than adult relatives.
In other words, each of the 3 subsamples showed deficits
in comparison with controls and the young offspring po-
sition was between patients and adult relatives (although
their 95% CI did overlap), as offspring will eventually
become nonaffected relatives or patients. For VisEM,
the nonaffected relatives appeared different from the
Fig.1.MeanEffectSizesfortheFullNeuropsychologicalBatteryinYoungHigh-RiskOffspring,NonaffectedAdultRelatives,andPatientsin
Comparison With Normal Controls. Effect sizes (ESs) were calculated using the difference of adjusted means (LSMeans) between the
experimentalandcontrolgroupsstandardizedbyapooledSD.ThepooledSDwasobtainedbydividingtheSEofthedifferenceofLSMeans
by the square root of 1
n1 þ 1
n2.
25 High-risk (HR) offspring are represented by an orange box (n), patients are represented by a black circle (d),
andnonaffectedadultrelatives(NAARs)arerepresentedbyagreentriangle(:).ThesignoftheESvalueswaschangedforsometestsinorder
tohavethedysfunctionalpolesinnegativevalues.Onthisfigure,thezerovalueindicatesd50,ie,nodifferencewithcontrols.Verbalepisodic
memory (VEM) is included in a blue box and refers to the California Verbal Learning Test (CVLT) total recall and delayed recall subtests.
Visualepisodicmemory(VisEM)isrepresentedbyapinkboxandreferstotheReyComplexFigureTestimmediateanddelayedrecallsubtests.
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Selective Generational Patterns of Verbal and Visual Memoryyoung offspring and patients, the 2 latter groups having
overlapping values in terms of difference with controls.
figure 3 illustrates further the 2 distinct generational
patterns observed for VEM and for VisEM.
Discussion
Memory Impairments in Offspring, Nonaffected and
Affected Adults
In these members of Eastern Que ´bec kindreds densely
affectedbySZ orBP,weobservedsizeableepisodicmem-
orydeficits,bothverbalandvisual.Thepresentsampleof
young offspring, as our former smaller sample,
10 showed
deficits in both VEM and VisEM. Byrne et al
28 in the
EdinburghHRStudyalsoobservedmemoryimpairments
in offspring of SZ. The observed impairments in our off-
springareunlikely tobeduetoaprodromalstate because
thememorydeficitswereseeninboththeveryyoungandin
the older offspring of our sample. It should be noted that
the young offspring subsample is much younger than the
age of disease incidence and consequently includes many
future patients. This is not the case for the nonaffected
adultrelativeswhoareonaverageolderthantheageofin-
cidence and are unlikely to develop the disease later. This
mightpartlyexplainwhysomeofthehighESsobservedin
theoffspringarehigherthanthosefoundinthenonaffected
adult relatives.
In the adult relatives, the observed VEM deficits (ES ;
 0.6)wereverysimilartothosealreadyreportedinmeta-
analyses of studies of relatives of SZ or BP.
3,5,29 Among
the many domains assessed with our battery, the largest
cognitive difference in relatives and in offspring appeared
tobeforVEMwhichisagaincongruentwiththeprevious
meta-analyses of relatives. The subgroup of nonaffected
adult relatives with a nonpsychotic axis I diagnosis and
the subgroup without showed nearly the same differences
from controls in terms of ES (result not shown) which is
congruent with the report of Gur et al.
30
In our kindreds, the patients affected by SZ or BP also
presented large ESs for VEM and VisEM that were com-
parablewiththoseobtainedinmeta-analysesofstudiesof
SZ
1 and BP
3 patients. Also, congruent with former stud-
ies,
31 the memory impairments in the present BP patients
were of a lesser magnitude, lying in an intermediate po-
sition between controls and SZ patients. It is noteworthy
that we replicate the recent VisEM findings of Skelley
et al,
5 who showed the presence of VisEM deficits in
SZ patients contrasting with an absence of such deficits
in their nonaffected adult relatives. Overall, the observed
cognitive impairments are consistent with findings
reported in other samples in which familial loads for
psychosis were less marked.
Developmental/Generational Memory Deﬁcits From the
Young Offspring up to the Adult Generation
The current study is the first, to our knowledge, to use
such cross-sectional family data to inspect potential dif-
ferential patterns betweenVEM and VisEM impairments
across generations, ie, in the period preceding disease
onset up to adulthood. Our observations have implica-
tions in 3 respects, as discussed below: (1) the distinct
developmental trajectories of the verbal and the visual
domains, (2) the use of VEM or VisEM as phenotypes
in genetic studies, and (3) the potential heterogeneity
in pathogenesis starting early in the life in the individual
at risk. Overall, our findings suggest that all cognitive
domains cannot be treated or modeled in the same man-
ner in prevention or genetic studies.
32
Fig. 2. Confidence Intervals (95%) of Effect Sizes Obtained in
Offspring, Nonaffected Adult Relatives, and Patients. Each of the
3subsampleswascomparedwithitshealthycontrolgroup.PanelA.
Verbal episodic memory (VEM) (California Verbal Learning Test
[CVLT] total recall). Panel B. Visual episodic memory (VisEM)
(Reydelayedrecall).High-risk(HR)offspringarerepresentedbyan
orange box (n), patients are represented by a black circle (d), and
nonaffected adult relatives (NAARs) are represented by a green
triangle (:).
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VEM can reflect, at the neuropsychological level, ele-
m e n t so fr i s ks h a r e di nS Za n dB Pa n dt r a n s m i t t e d
within these high-risk families. VEM impairments
would stand as an intermediate phenotype allowing
the detection of gene carriers not expressing the DSM
syndrome among nonaffected adult relatives and unaf-
fected offspring.
32,33 Such a pattern is suggested by the
findings of figure 2 in which each of the 3 subsamples
showed deficits in comparison with controls with the
offspring position located between that of patients
and adult relatives (although their 95% CI did overlap),
as young offspring will eventually become nonaffected
adult relatives or patients.
In contrast, VisEM deficits were absent in the nonaf-
fected adult relatives but were apparent both in patients
and young offspring. This suggests that the trajectory as-
sociated with VisEM would offer a better potential than
VEM to predict future risk of developing the disease.
Although VisEM has so far been less investigated than
VEMinmajorpsychiatricdisorders,
5theobserveddiffer-
ences in generational patterns might reflect 2 relatively
independent or heterogeneous developmental pathways
with different gene-environment risk mechanisms from
the early years to adulthood. To further test this hypoth-
esis, we computed the correlation between VEM and
VisEM performance in the offspring which was low
and nonsignificant (r = .17, P = .21). Interestingly, the re-
centresultsfromtheDunedinbirthcohort
34alsodetected
2 different longitudinal pathways leading to psychosis,
characterized by 2 different clusters of cognitive dysfunc-
tions. Hence,as alreadysuggested,
21,35,36 determinants of
Fig. 3. Trajectories Associated with Verbal Episodic Memory (VEM) and Visual Episodic Memory (VisEM) According to a Generational
Pattern. VEM was measured by the California Verbal Learning Test (CVLT) total recall (panel A), and VisEM was measured by the Rey
delayed recall (panel B). Affected means adult subjects affected by SZ or BP. Nonaffected means subjects not affected by SZ or BP, ie,
nonaffected adult relatives (NAARs) and high-risk (HR) offspring.
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early years of life in individuals at risk.
Little is known about the potential adverse effect of
cognitive impairments in VEM or VisEM on the social
adaptation of children or adolescents at risk.
37–39 Future
research must take into consideration that the putative
heterogeneous pathways marked by VisEM or VEM def-
icits may result not only from gene-environment mecha-
nisms affecting neurodevelopment but also from
longitudinal mechanisms impacting negatively the social
development and self-image that can accentuate the risk
of later developing the disorder.
Cognitive Memory Patterns Shared by SZ and BP
Eventhoughthiswasnotthemaingoalofthisreport,itis
noteworthy that impairments in VEM and VisEM were
present in both the SZ and BP patients, as in former stud-
ies.
9,31 We had already reported such commonality in
memoryimpairmentsintheoffspringofSZorBPparents
from these kindreds.
10 This suggests that common dys-
functional neurodevelopmental pathways, influenced
by genes or/and environment, may have an expression
in cognition a long time before disease onset.
10,35 In con-
tinuity, other shared phenotypic and genetic susceptibil-
ity loci or genes have been extensively documentedfor SZ
and BP.
12,40–43 These commonalities do not necessarily
indicate that SZ and BP are the same disorder but rather
that they would share some genetic and neurodevelop-
mental causes, as this has also been recently suggested
by our physiological data in electroretinography in these
young offspring.
36 These phenotypic characteristics offer
severalpromisingavenuesforfutureetiologyandpreven-
tion research focusing on the longitudinal trajectories
of different disease precursors.
Strengths and Limitations
This study strengths reside in the longitudinal follow-up
of a large number of affected kindreds that permitted the
thorough characterization of different phenotypes, both
DSM diagnosis and neurocognition. The design also
allowed us to test cognitive functioning cross-sectionally,
using a generational paradigm looking at the young off-
spring unaffected by SZ or BP vs the adult family mem-
bers who were either affected or nonaffected by the
disease. However, one must first remember that the pres-
entyoungoffspringhadnotyetreachedtheageofdisease
incidence and that the present study was not a long-term
longitudinal study of these offspring. Second, it is un-
likely that the observed generational patterns in visual
and verbal were due to peculiarities of our young and
adult control groups. table 1 and Supplementary table
S1 report an overall 3 point difference of performance
in raw scores on the RCF Test between the young and
adult control groups. Incidentally, such a drop in the
raw scores between the age 17 and 40 is also reported
in the normative values (Supplementary table S2, supple-
mental data).
44 Third, we cannot rule out the possibility
that differences in the proportions of sibs, offspring, or
parents in the different subsamples may have biased
our results. However, such a possibility is unlikely given
the recent meta-analysis of Snitz et al
45 which showed
that cognitive dysfunctions in nonaffected adult relatives
did not vary with the different types of relatives. Finally,
one must keep in mind that, due to the heavy risk setting
related to the familial loading of the present sample, the
generalization of the results to all the patients, the non-
affected adult relatives, or the HR offspring of the gen-
eral population requires caution.
Supplementary Material
Supplementary material is available at http://
schizophreniabulletin.oxfordjournals.org.
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